These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21228609)

  • 21. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Peña S; Baccichet E; Urbina M; Carreira I; Lima L
    Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirtazapine for depression and comorbidities in older patients with cancer.
    Raji MA; Barnum PD; Freeman J; Markowitz AB
    Ann Pharmacother; 2007 Sep; 41(9):1548-9. PubMed ID: 17623755
    [No Abstract]   [Full Text] [Related]  

  • 23. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
    Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mania associated with mirtazepine treatment and mixed depression.
    Habermeyer B; Bayer U; Müller-Spahn F
    Pharmacopsychiatry; 2010 Jan; 43(1):37-8. PubMed ID: 20178094
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression.
    Borkowska A; Drozdz W; Ziółkowska-Kochan M; Rybakowski J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):131-6. PubMed ID: 18399031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of an antidepressant: mirtazapine.
    Preskorn SH
    J Clin Psychiatry; 1997; 58 Suppl 6():3-8. PubMed ID: 9227668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysthymic disorder: treatment with mirtazapine.
    Dunner DL; Hendrickson HE; Bea C; Budech CB; O'Connor E
    Depress Anxiety; 1999; 10(2):68-72. PubMed ID: 10569129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional dyspepsia and mirtazapine.
    Lee SY; Rho SH; Choi SC
    Can J Psychiatry; 2002 Aug; 47(6):582-3. PubMed ID: 12211889
    [No Abstract]   [Full Text] [Related]  

  • 31. Mirtazapine for alcohol dependence: a case report.
    Crockford DN; White WD
    J Clin Psychiatry; 2005 Apr; 66(4):540. PubMed ID: 15816801
    [No Abstract]   [Full Text] [Related]  

  • 32. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
    Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
    [No Abstract]   [Full Text] [Related]  

  • 33. [Depression after first myocardial infarction. A prospective study on incidence, prognosis, risk factors and treatment].
    Strik JJ; van Praag HM; Honig A
    Tijdschr Gerontol Geriatr; 2003 Jun; 34(3):104-12. PubMed ID: 12866252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mirtazapine: other indications.
    Falkai P
    J Clin Psychiatry; 1999; 60 Suppl 17():36-40; discussion 46-8. PubMed ID: 10446741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antidepressant mirtazapine on fibromyalgia symptoms.
    Samborski W; Lezańska-Szpera M; Rybakowski JK
    Rocz Akad Med Bialymst; 2004; 49():265-9. PubMed ID: 15631355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Schwarz M; Rupprecht R; Romeo E
    Psychoneuroendocrinology; 2007 Jul; 32(6):669-80. PubMed ID: 17560730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of mianserin (Lerivon) in various forms of depression.
    Florkowski A; Kocur J; Rydzyński Z
    Act Nerv Super (Praha); 1989 Apr; 31(1):25-6. PubMed ID: 2781993
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
    Schüle C; Romeo E; Uzunov DP; Eser D; di Michele F; Baghai TC; Pasini A; Schwarz M; Kempter H; Rupprecht R
    Mol Psychiatry; 2006 Mar; 11(3):261-72. PubMed ID: 16344854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.